Progress for Stem Cell Therapy for Stroke

A recently published study, performed at Stanford University and University of Pittsburgh, demonstrated in a small group of patients that improvement can occur even years following a stroke. Human adult stem cells were injected directly into the brains of patients who had suffered strokes between six months and three years following the procedure. This small … Read more…

Cost of Stroke Treatment Rises

The only available drug for the treatment of the most common type of stroke is the clot buster known as tPA. This treatment was first approved by FDA 20 years ago. The cost of tPA jumped by 111% between 2005 and 2014, but reimbursement rose by only 8%, reported Dawn Kleindorfer, MD, University of Cincinnati, … Read more…

Progress for Interventional Stroke Therapy

In 1995 the clot dissolving drug tPA was first demonstrated to be effective in the treatment of the most common type of stroke, those caused by blood clots plugging arteries in the brain. Since that time, no newer therapy has been proven to improve the outcome of stroke patients compared to tPA. But tPA treatment … Read more…